Glipizide Tablet, Extended Release
Product Images NDC 82868-035

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 82868-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82868-035-30 (82868 035 30 Rev A 01 24)

Label for Glipizide Extended-Release Tablets, 10 mg, with a quantity of 30 tablets. The label includes storage instructions (20°-25°C), warnings to keep out of reach of children and protect from moisture, and notes the product is Rx only. The label lists Northwind Pharmaceuticals as the manufacturer and includes NDC 82868-035-30.*

FDA Label Image

Chemical Structure (Glipizide Str)

Chemical structure of Glipizide shown with detailed molecular arrangement, including rings, functional groups, and bonds, illustrating the active ingredient's molecular composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.